Parra Raul Jr. 4
4 · MERIT MEDICAL SYSTEMS INC · Filed Mar 6, 2025
Insider Transaction Report
Form 4
Parra Raul Jr.
CFO AND TREASURER
Transactions
- Exercise/Conversion
Common Stock, No Par Value
2025-03-05$37.71/sh+5,361$202,163→ 29,562 total - Sale
Common Stock, No Par Value
2025-03-05$103.58/sh−5,361$555,292→ 24,201 total - Exercise/Conversion
Non-qualified stock options (right to buy)
2025-03-05−5,361→ 0 totalExercise: $37.71From: 2021-02-26Exp: 2027-02-26→ Common Stock (5,361 underlying)
Holdings
- 2,770(indirect: By 401(k))
Common Stock, No Par Value
- 9,681
Non-qualified stock options (right to buy)
Exercise: $56.25From: 2022-03-19Exp: 2028-03-19→ Common Stock (9,681 underlying) - 14,570
Non-qualified stock options (right to buy)
Exercise: $65.03From: 2023-02-28Exp: 2029-02-28→ Common Stock (14,570 underlying) - 13,576
Non-qualified stock options (right to buy)
Exercise: $70.58From: 2024-02-28Exp: 2030-02-28→ Common Stock (13,576 underlying)
Footnotes (6)
- [F1]Represents plan holdings as of 2/28/2025.
- [F2]The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $103.00 to $103.695, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
- [F3]Becomes exercisable in equal annual installments of 25% commencing 02/26/2021.
- [F4]Becomes exercisable in equal annual installments of 25% commencing on 03/19/2022.
- [F5]Becomes exercisable in equal annual installments of 25% commencing on 02/28/2023.
- [F6]Becomes exercisable in equal annual installments of 25% commencing 02/28/2024.